Keyphrases
Myocarditis
86%
Immune Checkpoint Inhibitors
71%
Immune Checkpoint Inhibitor Myocarditis
41%
Cardiac Events
33%
Cardiovascular Magnetic Resonance
27%
Hypertension
20%
Carfilzomib
18%
Adverse Cardiac Events
18%
Multiple Myeloma
18%
Patients with Cancer
17%
Sinus of Valsalva Aneurysm
16%
Global Radial Strain
16%
Wolff-Parkinson-White Pattern
16%
Patients with Prostate Cancer
16%
Clinical Benefit
16%
Appendiceal Adenocarcinoma
16%
Trametinib
16%
Strain Event
16%
Retrospective Cohort Study
16%
Myocardial T2 Mapping
16%
Androgen Receptor Targeted Therapy
16%
Influenza Vaccination
16%
Coronary Resistance
16%
Spasmogens
16%
Odds Ratio
16%
Multiple Myeloma Patients
16%
Circumferential Strain
16%
Chest Pain Syndromes
16%
Paradigm Change
16%
Meta-analysis of Randomized Controlled Trials
16%
Previously Treated
16%
Cardiovascular Toxicity
16%
Immune Checkpoint
16%
T1 Mapping
16%
Protease Inhibitors
16%
Global Longitudinal Strain
16%
Surgical Repair
16%
Magnetic Resonance
16%
Vascular Reactivity
16%
Cardio-oncology
16%
Vascular Tone
16%
Cancer Therapy
16%
Myocardial T1 Mapping
16%
Wall Motion Abnormalities
16%
Stress Echocardiogram
16%
Major Adverse Cardiovascular Events
15%
Confidence Interval
15%
Targeted Agents
12%
Androgen Receptor
12%
Hazard Ratio
12%
Medicine and Dentistry
Myocarditis
66%
Immune Checkpoint Inhibitor
64%
Oncology
33%
Cancer Therapy
33%
Cardiovascular System
30%
Cardiac Magnetic Resonance Imaging
26%
Malignant Neoplasm
25%
Cardiovascular Disease
23%
Thorax Pain
20%
Diagnosis
19%
Trametinib
16%
Nuclear Magnetic Resonance
16%
Grand Rounds
16%
Adenocarcinoma
16%
Pain
16%
Cardiotoxicity
16%
Aneurysm
16%
ECG Abnormality
16%
Echocardiography
16%
Drug Therapy
13%
Gadolinium
12%
Surgery
12%
Fistula
12%
Electrocardiogram
12%
Heart Left Ventricle Ejection Fraction
12%
Cancer Mortality
8%
Cardiac Care
8%
Pre-Excitation Syndrome
8%
Clear Cell Renal Cell Carcinoma
8%
Vasculotropin Inhibitor
8%
Cancer Treatment
8%
Pharmacogenetics
8%
Tyrosine-Kinase Inhibitor
8%
Case Presentation
8%
Bevacizumab
8%
Heart Failure
8%
Tau
8%
Drug Interaction
8%
Cardiovascular Mortality
8%
Drug Intolerance
8%
Side Effect
8%
Clinical Oncology
8%
Cisplatin
8%
Erythropoietin
8%
Carfilzomib
8%
Anticarcinogen
8%
Personalized Medicine
8%
Cardiovascular Effect
8%
QRS Interval
7%
Major Adverse Cardiac Event
6%
Pharmacology, Toxicology and Pharmaceutical Science
Myocarditis
100%
Immune Checkpoint Inhibitor
97%
Malignant Neoplasm
20%
Carfilzomib
18%
Multiple Myeloma
18%
Major Adverse Cardiac Event
16%
Prostate Cancer
16%
Vaccination Policy
16%
Proteasome Inhibitor
16%
Randomized Controlled Trial
16%
Androgen Receptor
16%
Cohort Study
16%
Cardiovascular Toxicity
16%
Cardiovascular Disease
16%
Gadolinium
14%
Cardiogenic Shock
8%
Complete Heart Block
8%
Heart Arrest
7%
Adverse Event
6%
Heart Infarction
5%
